The interim results of the World Health Organization’s massive Solidarity Therapeutics Trial are in — and they don’t bode well for remdesivir, the antiviral drug that for months was touted as a moderately effective treatment for Covid-19, and three other drugs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,